Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Mentor Corporation |
---|---|
Information provided by: | Mentor Corporation |
ClinicalTrials.gov Identifier: | NCT00811525 |
The Contour Profile Gel Continued Access Study is designed to demonstrate safety and effectiveness of Mentor's Mammary Prostheses in women who are undergoing primary augmentation, primary reconstruction, or revision. Safety information on the rate of capsular contracture, rupture, and infection will be collected, and used to help determine device safety.
Condition | Intervention |
---|---|
Breast Augmentation Breast Reconstruction Breast Revision |
Device: Mentor Siltex® Contour Profile Gel Mammary Prosthesis |
Study Type: | Expanded Access |
Official Title: | Continued Access Study of the Safety and Effectiveness of Mentor Siltex® Contour Profile Gel Mammary Prostheses in Patients Who Are Undergoing Primary Breast Augmentation,Primary Breast Reconstruction or Revision |
Study Start Date: | August 2004 |
Silicone gel-filled breast implants were introduced in the early sixties and were in wide-scale distribution by the time the Medical Device Amendments to the Food Drug and Cosmetic Act was passed in 1976. In 1983, gel-filled breast implants were designated as Class III devices requiring premarket approval.
In May 1990, the Food and Drug Administration (FDA) published a proposed request (515(b)) for Premarket Approval Applications (PMA) and in April 1991 published the final request. This final publication put manufacturers of gel-filled breast implants on notice that for continued marketing of gel-filled breast implants, a PMA was due to FDA in 90 days from the final publication date.
A premarket approval (PMA) for the Mentor gel-filled breast implants was filed with the FDA in July 1991. At the FDA General and Plastic Surgery Advisory Committee meeting in November 1991, the committee recommended the submission of additional information to establish the safety and effectiveness of gel-filled breast implants.
In January 1992, the FDA Commissioner announced a voluntary moratorium of the sale of gel-filled breast implants to allow the advisory panel time to assess additional information. In April 1992, the moratorium was lifted but only for reconstruction and revision patients. Every patient implanted had to be part of an adjunct study, and had to be offered participation in a registry of gel-filled breast implant patients. In order to be implanted with gel-filled implants for augmentation, women had to be enrolled in a core clinical study.
In September of 2000 the Core Gel study began, leading the way to the November 2006 FDA approval of the Core Gel implant or Memory Gel breast implant.
The objective of the Contour Profile Gel Continued Access is to determine the safety and effectiveness of the Silicone Contour Profile Gel Mammary Prostheses in women who are undergoing primary breast augmentation, primary breast reconstruction, or revision. While Core CPG patient follow-up is being completed, this Continued Access Study is designed to enroll patients at a limited rate per month to allow for continued physician experience with the device and to collect additional safety data to support a future PMA. Safety data will be collected and submitted as supplemental data. The CPG-CA has the same investigators and surgical sites as in the Core CPG Study.
In the duration of this study, patients are required to have follow-up visits at 10 weeks post-surgery and every year after surgery through the 10th year of completion as in the Core CPG study. Unlike the Core CPG study, the CPG-CA study does not have a randomized selection of MRI patients as a required component of the study.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Inclusion Criteria:
A candidate for:
Exclusion Criteria:
Contact: Quinton T Marquiss | qmarquiss@mentorcorp.com |
Principal Investigator: | William Adams, M.D. | Dallas, TX |
Principal Investigator: | Dwight Baker, M.D. | Dothan, AL |
Principal Investigator: | Frank Barone, M.D. | Toledo, OH |
Principal Investigator: | Joseph Bauer, M.D. | Alpharetta, GA |
Principal Investigator: | Michael Bentley, M.D. | Montgomery, AL |
Principal Investigator: | John Bishop, M.D. | Greenville, SC |
Principal Investigator: | David Caplin, M.D. | St. Louis, MO |
Principal Investigator: | E. Dale Collins, M.D. | Lebanon, NH (Dartmouth-Hitchcock) |
Principal Investigator: | Craig Colville, M.D. | Toledo, OH |
Principal Investigator: | Gloria Duda, M.D. | McLean, VA (D.C. Metro area) |
Principal Investigator: | Barry Fernando, M.D. | Phoenix, AZ |
Principal Investigator: | William Gorman, M.D. | Austin, TX |
Principal Investigator: | Scot Glasberg, M.D. | New York, NY |
Principal Investigator: | Strawford Dees, M.D. | Biloxi, MS |
Principal Investigator: | Dennis Hammond, M.D. | Grand Rapids, MI |
Principal Investigator: | Mark Jewell, M.D. | Eugene, OR |
Principal Investigator: | Robert Kevitch, M.D. | Allentown, PA |
Principal Investigator: | Shujaat Khan, M.D. | Fort Worth, TX |
Principal Investigator: | Philip Kierney, M.D. | Puyallup, WA |
Principal Investigator: | John Lettieri, M.D. | Spartanburg, SC |
Principal Investigator: | Tim Love, M.D. | Oklahoma City, OK |
Principal Investigator: | Mark Migliori, M.D. | Edina, MN |
Principal Investigator: | Renato Ocampo, M.D. | Boca Raton, FL |
Principal Investigator: | Bradley Remington, M.D. | Kirkland, WA |
Principal Investigator: | Paul Silverstein, M.D. | Oklahoma City, OK |
Principal Investigator: | John Smoot, M.D. | La Jolla, CA |
Principal Investigator: | Grant Stevens, M.D. | Marina Del Rey, CA |
Principal Investigator: | Steven Teitelbaum, M.D. | Santa Monica, CA |
Principal Investigator: | Lewis Berger, M.D. | Tampa, FL |
Responsible Party: | Mentor Corporation ( Nicola Selley/Vice President of Clinical and Regulatory Affairs ) |
Study ID Numbers: | 110390CA-0204-2 |
Study First Received: | December 17, 2008 |
Last Updated: | March 3, 2009 |
ClinicalTrials.gov Identifier: | NCT00811525 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Breast Augmentation Breast Reconstruction Breast Revision |
Silicone gel Contour Profile Gel Siltex |